Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
5m agoZacks Small-Cap Research Raises FatPipe (NASDAQ:FATN) Valuation from $6.00 to $6.40 per Share Following Preliminary Fiscal Fourth Quarter Business Update
5m agoMEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE)
5m agoVS Media Enters the AI Smart Living Sector to Explore New Growth Opportunities
32m agoGalderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
32m agoSurface Transforms plc – in Administration, Sale of Business and Assets
Prescient Therapeutics Limited logo

Prescient Therapeutics Limited

About

0.08AUD+0.01 +13.89%
Closed • Updated at 17:07 GMT+00:00
Market Cap$54.08M
Volume2.10M
Beta1.32
RSI71.33
Health TechnologyBiotechnology

Prescient Therapeutics Limited — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 30 2026
March 2026 Quarterly Update and Appendix 4C
Feb 24 2026
Appendix 4D and Half Year Financial Report
Jan 30 2026
December 2025 Quarterly Update and Appendix 4C
Dec 15 2025
PTX secures EU Authorisation to commence PTX-100 Trial
Nov 19 2025
PTX secures EU Orphan Drug Designation for PTX-100 in CTCL

Community Chat

Ask AI

6ix6ixAIEvents